Autres langues Caleminder Inc.

Actions

Temps Différé OTC Markets Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		-.--%	-.--%

20/06	Clearmind Medicine signe un accord pour obtenir les droits mondiaux pour le développement et la commercialisation de composés psychédéliques pour le SSPT	MT
23/02	Clearmind Medicine dit qu'Israël approuve le début de l'essai clinique du CMND-100 pour les troubles liés à l'utilisation de l'alcool	MT

Clearmind Medicine Signs Agreement to Secure Global Rights for Psychedelic Compound Development, Commercialization for PTSD	20/06
Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder	23/02
Clearmind Medicine Receives Patent Approval in China	05/02
Sector Update: Health Care	11/01
Top Midday Decliners	11/01
Top Premarket Decliners	11/01
Top Midday Gainers	10/01
Sector Update: Health Care Stocks Ease Late Afternoon	05/12
Top Midday Gainers	05/12
Top Premarket Gainers	30/11
Sector Update: Health Care Stocks Retreat in Late Afternoon	28/11
Top Midday Gainers	28/11
Clearmind Medicine Closes $2.25 Million Public Offering Exclusive to US	18/09/23
Sector Update: Health Care Stocks Rising Late Afternoon	14/09/23
Sector Update: Health Care Stocks Rising in Afternoon Trading	14/09/23
Sector Update: Health Care	14/09/23
Clearmind Medicine Prices $2.25 Million Public Offering	14/09/23
Sector Update: Health Care Stocks Falling Late Afternoon	06/09/23
Sector Update: Health Care Stocks Down in Afternoon Trading	06/09/23
Clearmind Adds Johns Hopkins University For CMND-100 Trial in Patients With Alcohol Use Disorder	06/09/23

Aucun résultat pour cette recherche